Skip to main content
. Author manuscript; available in PMC: 2021 Feb 15.
Published in final edited form as: J Hazard Mater. 2019 Sep 24;384:121306. doi: 10.1016/j.jhazmat.2019.121306

Table 2.

Consumption rate of drugs in urban A, urban B, and a rural community in Kentucky, U.S. The values in parenthesis represent the 95% confidence interval.

Analytes Consumption Rate (mg/d/1000 people)
(95% Confidence Interval)
Mean difference
(95% Confidence Interval)
Urban A Urban B Rural Urban A - Urban B Urban A - Rural Urban B - Rural
Stimulants
Cocaine (CCN)* 3830 (2850, 5060) 1850 (1170, 2780) 864 (471, 1440) 1980 (785, 3250) 2960 (1920, 4200) 984 (149, 1970)
Cocaine** 2790 (2040, 3710) 1180 (748, 1760) 363 (199, 603) 1610 (698, 2600) 2430 (1650, 3350) 816 (332, 1430)
Amphetamine (AMP) 400 (279, 556) 344 (208, 535) 738 (446, 1100) 344 (208, 535) −338 (−677, −43) −393 (−748, −78)
Methamphetamine (MAPT) 1030 (721, 1400) 1160 (694, 1790) 1660 (985, 2460) 1160 (694, 1790) −629 (−1430, 81) −276 (−1260, 581)
Methylphenidate (MPD) 284 (185, 398) 290 (198, 415) 605 (372, 885) −6 (−163, 142) −321 (−616, −62) −315 (−611, −50)
Opioids/Narcotics
Heroin* (HER) 1620 (961, 2700) 1810 (600, 3610) n/a −187 (−1730, 1130) n/a n/a
Morphine (MPH) 312 (208, 452) 229 (140, 357) 99 (54, 167) 83 (−46, 214) 213 (107, 345) 130 (34, 254)
Methadone* (MTD) 106 (65, 178) 92 (53, 160) 1410 (708, 2600) 14 (−31, 60) −1300 (−2450, −620) −1317 (−2490, −635)
Methadone** 449 (289, 716) 428 (253, 716) NA 21 (−178, 204) NA NA
Codeine (CDN) 50 (31, 86) 52 (28, 96) 192 (87, 388) −2 (−32, 21) −142 (−320, −44) −140 (−319, −42)
Fentanyl (FNT) 169 (85, 391) 134 (54, 324) 31 (13, 72) 35 (−57, 150) 138 (66, 327) 103 (32, 267)
Oxycodone (OCD) 566 (272, 1060) 459 (232, 866) 465 (217, 919) 107 (−230, 474) 101 (−281, 488) −6 (−367, 325)
Hydrocodone (HCD) 166 (126, 213) 134 (93, 189) 507 (289, 820) 33 (−35, 95) −341 (−657, −118) −373 (−689, −149)
Hydromorphone (HMP) 67 (51, 87) 40 (28, 56) 142 (82, 226) 27 (4, 51) −75 (−161, −11) −102 (−187, −40)
Buprenorphine (BPN) 1700 (1220, 2260) 1480 (975, 2150) 3150 (1800, 5030) 219 (−568, 955) −1450 (−3370, −2) −1670 (−3600, −176)
Hallucinogens
MDMA 28 (19, 40) 21 (11, 36) n/a 7 (−10, 21) n/a n/a
MDEA 25* < LOQ n/a n/a n/a n/a
MDA 6 (5, 8) < LOQ n/a n/a n/a n/a
THC* 88100 (54000-134000) 78700 (48500-122000) n/a 9400 (−35500-53200) n/a n/a
Antischizophrenics
Quetiapine (QTP) 31 (26, 36) 33 (21, 48) 31 (18, 49) −2 (−21, 14) 0 (−22,17) 2 (−22, 18)
Sedatives-Hypnotics-Anxiolytics
Lorazepam (LZP) 8 (5, 10) 12 (8, 17) 26 (16, 37) −4 (−11, 1) −14 (−29, −4) −14 (−27, −4)
Alprazolam (APZ) 66 (53, 81) 68 (49, 94) 30 (17, 50) −2 (−31, 23) 36 (13, 56) 38 (10, 68)
Diazepam (DZP) 3 (2, 5) < LOQ 4 (2, 4) n/a −1 (−3, 2) n/a
Oxazepam (OXZ) 3 (2, 5) 4 (2, 7) 40 (23, 63) −1 (−4, 2) −37 (−60, −20) −36 (−59, −19)
Temazepam (TMZ) 16 (10, 23) 37 (24, 55) 83 (48, 132) −21 (−40, −6) −67 (−116, −32) −46 (−96, −7)
Carbamazepine (CRB) 749 (567, 959) 1580 (1000, 2350) 615 (347, 1000) −835 (−1620, −217) 134 (−289, 479) 969 (279, 1780)
Antidepressants
Sertraline (SRT) 11700 (7960, 15100) 14300 (9020, 21400) 4030 (2180, 6730) −2700 (−11600, 4610) 7620 (2550, 12,150) 10300 (5230, 14000)
Fluoxetine (FLX) 581 (459, 724) 787 (547, 1110) 210 (115, 349) −206 (−547, 73) 371 (192, 545) 577 (304, 923)
Venlafaxine (VNF) 4750 (3470, 6240) 6230 (4200, 8960) 5450 (3150, 8720) −1480 (−4400, 1010) −705 (−4160, 2020) 775 (−3060, 4350)
Citalopram (CTP) 916 (536, 1600) 1080 (599, 1940) 1160 (565, 2250) −159 (−720, 285) −248 (−1060, 323) −89 (−909, 603)
*

based on the concentration of a metabolite

**

based on the concentration of residual parent drug; bolds values are significantly different (range of mean difference did not include zero); < LOQ: below the limit of quantitation, n/a: non-applicable.